Zhang Shuangqing | cognition | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Zhang Shuangqing | cognition | Best Researcher Award

Dr. Shuang-Qing Zhang is a distinguished professor at the Department of Nutrition and Metabolism, National Institute for Nutrition and Health, Chinese CDC, Beijing. With a robust academic background in pharmaceutics and over two decades of research experience, he has significantly contributed to the fields of pharmacokinetics, nutritional toxicology, and functional food safety. His global expertise is enriched through international collaborations, notably as a visiting senior fellow at the National University of Singapore and postdoctoral research in the USA. Dr. Zhang is a prolific author with numerous high-impact publications and is a respected editor across 20+ international journals. His research interests span selenium and cognitive function, nanoparticle drug delivery, and health food safety evaluation. He actively serves on multiple scientific committees and advisory boards in China. Through his innovative projects and policy-informing studies, Dr. Zhang continues to shape national nutrition, drug safety, and public health discourse.

Profile

🎓 Education

Dr. Shuang-Qing Zhang holds a Ph.D. in Pharmaceutics from Peking University (2002–2005), after earning both B.S. and M.S. degrees in Pharmaceutics from Shenyang Pharmaceutical University (1995–2002). His academic foundation was solidified through extensive training in drug formulation, pharmacokinetics, and pharmaceutical sciences. He further advanced his expertise as a postdoctoral researcher at the University of Mississippi and Texas Tech University (2005–2008), focusing on drug metabolism and toxicokinetics. In 2013–2014, he served as a Visiting Senior Research Fellow at the Yong Loo Lin School of Medicine, National University of Singapore, where he explored translational nutrition research. This diverse and international academic training underpins his authoritative voice in pharmaceutics, toxicology, and nutrition science, and continues to inform his interdisciplinary research on health food safety, pharmacodynamics, and nanomedicine.

🧪 Experience

Dr. Zhang began his professional journey as a postdoctoral researcher in the United States before returning to China as an Associate Professor at the National Institutes for Food and Drug Control (2010–2012), specializing in drug metabolism and safety. Since 2012, he has been a Professor at the Chinese CDC’s Department of Nutrition and Metabolism, leading pioneering work in nutritional toxicology, pharmacokinetics, and health food evaluation. He serves as an expert evaluator for China’s major scientific funding and regulatory agencies, including the National Natural Science Foundation and Ministry of Science and Technology. Dr. Zhang also plays advisory roles in national health committees related to environmental mutagens and food safety. His dedication extends to editorial duties for over 20 journals and authorship of influential monographs in toxicology and nutriomics. He actively mentors scholars, oversees major research grants, and contributes to national policy development in food and drug safety.

🏅 Awards and Honors

Dr. Zhang has earned national recognition through prestigious funding awards such as the National Natural Science Foundation of China, Scientific Research Foundation for Returned Overseas Chinese Scholars, and multiple provincial and national-level research programs. His leadership in interdisciplinary projects addressing osteoporosis, cancer drug development, and nanoparticle therapeutics has positioned him as a trusted advisor to government science bodies. In 2015 and 2019, he was a recipient of the National Publication Foundation Support for his authored books on nutriomics and medical foods. As an editorial board member and guest editor for numerous international scientific journals, Dr. Zhang has been honored for his editorial leadership and influence in the scientific publishing community. He is a Distinguished Professor at the Chinese Academy of Agricultural Sciences and a standing or core member of several scientific committees across nutrition, toxicology, pharmacology, and food science sectors.

🔬 Research Focus

Dr. Zhang’s research encompasses nutritional pharmacology, drug metabolism, toxicokinetics, and functional food safety. He is internationally recognized for his studies on selenium’s role in cognitive function, publishing extensively on selenium intake, pharmacokinetics, and its neuroprotective effects in aging populations. His lab investigates nanoparticle-based drug delivery systems, targeting conditions like postmenopausal osteoporosis and cancer, with a focus on osteoblast-specific biomimetic designs. Another focal point is the pharmacodynamics of poly(L-glutamic acid)-paclitaxel conjugates, offering solutions to multi-drug resistance. Dr. Zhang also leads efforts in evaluating the safety and bioavailability of functional foods, including selenium-, zinc-, and chromium-enriched yeasts, using advanced techniques like UPLC-MS/MS and ion chromatography. His interdisciplinary research integrates toxicology, nutrition, and pharmaceutical science to bridge clinical translation and public health applications, while also informing regulatory policy on dietary intake thresholds and novel drug safety assessments in China and beyond.

✅ Conclusion

Dr. Shuang-Qing Zhang is a globally respected professor and scientist whose impactful research on nutritional pharmacology, selenium neurobiology, and nanomedicine has significantly advanced food and drug safety, earning him national recognition, global collaborations, and editorial leadership.

Publications

1. Bai YZ, Gao YX, Zhang SQ*. Identification of factors on blood selenium levels
in the US adults: a cross-sectional study. Nutrients, 2024, 16(11): e1734.
2. Bai YZ, Zhang SQ*. Selenium intake is an effective strategy for the
improvement of cognitive decline in low cognition older Americans. Int J Food
Sci Nutr. 2024, 75(7): 687-694. (* corresponding author)
3. Bai YZ, Li JM, Zhang SQ*. A nonlinear association between total selenium
intake and blood selenium concentration: an analysis based on the National
Health and Nutrition Examination Survey 2011-2018. J Food Sci. 2024,
89(12): 9955-9967. (* corresponding author)
4. Li JM, Bai YZ, Liu QY, Zhang SQ*. Mediation effect of oxidative stress on the
association between selenium intake and cognition in American adults.
Nutrients, 2024, 16(23): e4163. (* corresponding author)

 

 

 

 

Azzeddine Charki | Neuropsychology | Best Researcher Award

Published on by Cognitive Scientist Awards

Assist. Prof. Dr. Azzeddine Charki | Neuropsychology | Best Researcher Award 

Dr. Azzeddine Charki is a Professor of Cognitive and Biological Psychology at the Faculty of Letters and Human Sciences Aïn Chock, Hassan II University, Casablanca. He holds a Ph.D. in Neuropsychology from Sidi Mohamed Ben Abdellah University, Fez. Dr. Charki is an esteemed researcher and active member of the Laboratory for Studies and Research in Cognitive and Human Sciences, focusing on psychology and language. With a strong dedication to cognitive psychology and neuropsychology, he supervises numerous research projects and contributes significantly to academic discourse. He has authored and co-authored several publications in high-impact journals on topics such as executive function, mentalizing, and neurodevelopmental disorders like ASD and ADHD. Fluent in Arabic, French, and English, he integrates pedagogical expertise with rigorous data analysis and project management. Dr. Charki’s commitment to advancing psychological science is matched by his passion for mentoring and fostering academic growth in his field.

Profile

🎓 Education

Dr. Azzeddine Charki earned his Ph.D. in Neuropsychology from Sidi Mohamed Ben Abdellah University, Fez. His doctoral work laid the foundation for his deep specialization in neuropsychology and cognitive sciences, particularly in executive function and mentalizing. Throughout his academic training, he developed a multidisciplinary understanding of brain-behavior relationships, integrating biological, cognitive, and social perspectives. His education emphasized both theoretical models and practical application in clinical and developmental contexts. Dr. Charki also received training in pedagogy, research methodology, and advanced data analysis techniques, which he continues to use in his academic career. His strong educational background has enabled him to contribute to Moroccan and international scholarship in cognitive and neuropsychology. His academic formation has also nurtured a strong inclination toward interdisciplinary research and collaborative knowledge production, particularly in the study of social cognition and neurodevelopmental disorders such as autism and ADHD.

🧪 Experience

Dr. Azzeddine Charki began his academic career as a Temporary Professor at Sidi Mohamed Ben Abdellah University, Fez (2020–2022), where he taught and conducted research in cognitive and neuropsychology. Since November 2023, he has been serving as Assistant Professor at the Faculty of Letters and Human Sciences Aïn Chock, Hassan II University, Casablanca. Over the years, he has supervised numerous undergraduate and postgraduate research projects and participated in collaborative initiatives within the university’s Laboratory for Studies and Research in Cognitive and Human Sciences. In addition to his teaching responsibilities, Dr. Charki has contributed extensively to the academic literature with a focus on executive functioning, theory of mind, and developmental psychopathology. His professional experience also includes project management, scientific writing, and dissemination of research findings. His bilingual and multicultural skills have allowed him to reach a wide range of students and researchers across Arabic, Francophone, and Anglophone academic contexts.

🏅 Awards and Honors

Dr. Azzeddine Charki has earned recognition primarily through his impactful research publications and academic service in Morocco’s leading institutions. Although specific named awards were not detailed, his repeated inclusion in peer-reviewed international and regional journals such as Applied Neuropsychology: Child, Neuropsychiatry and Neuropsychology, and the Arab Journal of Psychology signifies scholarly acknowledgment of his research excellence. His work on autism spectrum disorder, theory of mind, and executive functions reflects high intellectual merit and contributes meaningfully to both theoretical understanding and practical applications in neuropsychology. Dr. Charki’s mentorship of numerous student research projects and his active engagement in cross-disciplinary studies also underscore his standing as a respected academic. Being a core member of a cognitive science laboratory at Hassan II University further testifies to his leadership in scientific inquiry and academic collaboration. These contributions collectively demonstrate his respected status and growing impact in the field of cognitive psychology and neurodevelopmental research.

🔬 Research Focus

Dr. Charki’s research centers on cognitive psychology and neuropsychology, with particular interest in executive functions, social cognition, and neurodevelopmental disorders. He investigates mentalizing processes, especially the cognitive and affective domains of theory of mind in children with Autism Spectrum Disorder (ASD). His work explores both typical and atypical development, aiming to identify neural and behavioral mechanisms underlying disorders such as ASD and ADHD. He also delves into comparative frameworks across schizophrenia spectrum disorders, highlighting the neurobiological overlap in social cognition deficits. Dr. Charki integrates developmental psychology, neurobiology, and psychometric assessments to explore how children’s cognitive representations are structured and evolve in different socio-cultural contexts. His scholarly publications demonstrate a strong methodological foundation and innovative contributions to understanding how executive functions interact with social behavior. Furthermore, he actively examines Moroccan sociocultural representations in educational contexts, blending qualitative and quantitative approaches to enrich cognitive psychological theory and practice.

✅ Conclusion

Dr. Azzeddine Charki is a dedicated cognitive psychologist whose interdisciplinary research on executive function, mentalizing, and neurodevelopmental disorders enhances both scientific understanding and educational practice through a culturally grounded and evidence-based approach.

Publications

  • Charki, A., Zarbouch, B., Bouchala, C., & Meklaui, F., Z . (2024). Neuronal and developmental dimensions of mentalizing and it’s connection with executive functions. Arab Journal of Psychology. https://doi.org/10.57642/AJOPSY911

 

  • Charki, A., Meklaoui, F. Z., Charki, A., & Ettouzani, A. (2025). Examining the association between variation of ASD and cognitive and affective domains of mentalizing in verbal children with ASD. Applied Neuropsychology: Child, 1–11. https://doi.org/10.1080/21622965.2025.2504502

 

 

 

 

 

 

Aila Gareayaghi | Post-traumatic Stress Disorder | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Aila Gareayaghi | Post-traumatic Stress Disorder | Best Researcher Award

Dr. Aila Gareayaghi is a committed psychiatrist based in Kocaeli, Türkiye, with a deep passion for trauma-focused therapy, online psychotherapy, and mood and anxiety disorders. She holds the position of Lecturer and Psychiatrist at Kocaeli University and serves as Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye. Dr. Gareayaghi’s extensive clinical and academic work includes innovative research on telepsychiatry, particularly in post-disaster mental health following Türkiye’s 2023 Kahramanmaraş Earthquakes. Her international experience includes a clerkship at Johns Hopkins University, Maryland. Beyond her clinical practice, she is active in research, conference presentations, and has authored multiple peer-reviewed publications addressing PTSD, sexual dysfunction, and transphobia in healthcare. Dr. Gareayaghi is multilingual, speaks advanced English and elementary French, and is a passionate advocate for volunteerism, animal welfare, and nature conservation, integrating her holistic outlook into her psychiatric practice.

Profile

🎓 Education

Dr. Aila Gareayaghi began her academic journey with a High School Diploma from Matthew McNair Secondary School in Vancouver, Canada (2012). She earned her Doctor of Medicine (M.D.) from Bezmialem Vakıf University, Istanbul, Türkiye (2012-2018), where she built a strong foundation in medical sciences. During her medical training, she completed a prestigious clerkship in Gastroenterology at Johns Hopkins University, USA (2018), gaining international exposure to advanced clinical practices. Pursuing her passion for mental health, she specialized in Psychiatry at Kocaeli University, Türkiye (2020-2024). Under the mentorship of Prof. Dr. Elif Tatlıdil, she completed her thesis on “Telepsychiatry Services During the February 6 Earthquakes and PTSD Prevalence Six Months Later.” Additionally, Dr. Gareayaghi continuously expanded her expertise through numerous certifications in psychotherapy, cognitive behavioral therapy, dynamic psychotherapy, EMDR, and traditional Chinese medicine, emphasizing her dedication to comprehensive psychiatric care.

🧪 Experience

Dr. Gareayaghi’s professional experience reflects a blend of clinical practice, teaching, and research. She currently serves as Lecturer and Psychiatrist at the Department of Psychiatry, Kocaeli University (2024–Present), where she actively treats patients, mentors students, and conducts impactful research. As Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye, she plays a leadership role in advancing psychiatric practice and policy at the regional level. Her experience extends internationally, having completed a clinical clerkship in Gastroenterology at Johns Hopkins University, USA. Dr. Gareayaghi has presented her research extensively at national and international psychiatric congresses, covering topics from disaster psychiatry to psychosis and caregiver support. Her work demonstrates strong expertise in trauma therapy, online psychotherapy, and managing complex psychiatric conditions. She is also a prolific contributor to academic literature, authoring multiple peer-reviewed articles and book chapters addressing psychiatric emergencies and psychological trauma interventions.

🏅 Awards and Honors

Dr. Aila Gareayaghi has distinguished herself through numerous scientific contributions and recognitions. She has been invited as a speaker at prestigious forums such as the 59th National Psychiatry Congress and the Symposium on Disaster and Disaster Management. Her presentations on post-earthquake PTSD, antipsychotic-induced complications, and caregiver support have been recognized for their clinical relevance and academic rigor. Dr. Gareayaghi’s research, including peer-reviewed publications on telepsychiatry and transphobia in healthcare, reflects her innovative approach to contemporary psychiatric challenges. Although formal awards are not specified, her active involvement as Chair of the Kocaeli Branch of the Psychiatric Association of Türkiye and her multiple invited speaker roles demonstrate high professional regard and peer recognition. Moreover, her extensive certifications in psychotherapy modalities underscore her commitment to lifelong learning and excellence in patient care. Her dedication to volunteer work and animal welfare also highlight her compassionate engagement beyond academia.

🔬 Research Focus

Dr. Gareayaghi’s research focuses primarily on trauma-informed care, disaster psychiatry, and telepsychiatry, with a special emphasis on the mental health impact of natural disasters. Her thesis work examined the prevalence of PTSD following Türkiye’s 2023 earthquakes and the effectiveness of telepsychiatry services during disaster recovery. Additionally, her research explores societal and clinical aspects of sexual dysfunction, major depressive disorder, bipolar disorder, schizophrenia, and anxiety disorders. She has published studies addressing transphobia in healthcare, antipsychotic-induced complications, and innovative therapeutic interventions such as EMDR. Dr. Gareayaghi integrates various therapeutic modalities, including dynamic psychotherapy, cognitive behavioral therapy, and psychodynamic psychotherapy, into both her clinical practice and research. Her multidisciplinary approach bridges clinical psychiatry, public health, and social psychology, contributing valuable insights into the management of psychiatric emergencies and the psychological aftermath of crises. Her ongoing work continues to address evolving mental health challenges in both individual and systemic contexts.

✅ Conclusion

Dr. Aila Gareayaghi exemplifies a dynamic psychiatrist integrating clinical excellence, cutting-edge research, and compassionate care, with a focus on trauma therapy, disaster psychiatry, telepsychiatry, and comprehensive psychiatric education.

Publications

  • Ruh Sağlığında Kriz

    ÖGDA GAREAYAGHİ, UDH YILMAZ, A POLAT
    PSİKİYATRİK ACİLLER
  • A MEDICAL STUDENT’S PERSPECTIVE ON ANIMAL EXPERIMENTATION.
    A Gareayaghi
    The Turkish Journal of Gastroenterology: the Official Journal of Turkish …

  • Predictors of Transphobia and Attitudes Toward Transgender Individuals Among Nurses in Türkiye: A Cross-Sectional Study

    Healthcare
    2025-06-19 | Journal article
    DOI: 10.3390/healthcare13121474
    CONTRIBUTORS: Ezgi Şişman; Mehtap Güngör; Aila Gareayaghi; Hanife Yılmaz; Aslıhan Polat

  • Post-Earthquake PTSD and the Role of Telepsychiatry: A Six-Month Follow-Up Study After the 2023 Kahramanmaraş Earthquakes

    Medicina
    2025-06-17 | Journal article
    DOI: 10.3390/medicina61061097
    CONTRIBUTORS: Aila Gareayaghi; Elif Tatlıdil; Ezgi Şişman; Aslıhan Polat

  • Experiences with Brexpiprazole in the Management of Agitation Due to Dementia in a University Clinic: A Case Series

    Kocaeli Üniversitesi Sağlık Bilimleri Dergisi
    2025-03-21 | Journal article
    DOI: 10.30934/kusbed.1617807
    CONTRIBUTORS: Aila Gareayaghi; Ezgi Şişman; Mert Türksoy; Aslıhan Özlem Polat Işık

Dyandevi mathure | Nanoformulation for Alzheimer’s disease | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Dyandevi mathure | Nanoformulation for Alzheimer’s disease | Best Researcher Award

Dr. Dyandevi Mewalal Mathure, Assistant Professor at Bharati Vidyapeeth, Poona College of Pharmacy, Pune, is a distinguished academician with over 15 years of experience in pharmaceutical sciences. Holding a Ph.D. in Pharmaceutical Sciences, she has significantly contributed to teaching, research, and innovation. Dr. Mathure has authored three notable books, published 18 research articles in reputed journals, and holds five published patents. Her research primarily focuses on nanoformulations for Alzheimer’s disease, wound healing, and topical formulations for skin diseases. She has successfully completed government-funded research projects and is actively engaged in industry consultancy work. Collaborating with institutions like the University of Petroleum and Energy Studies, Dehradun, Dr. Mathure continues to push the frontiers of pharmaceutical research. Her dedication is reflected in multiple accolades, including best paper presentation awards at international conferences. Committed to translational pharmaceutical advancements, she remains a passionate contributor to academia and industry alike.

Profile

🎓 Education

Dr. Dyandevi Mewalal Mathure earned her Ph.D. in Pharmaceutical Sciences, building a robust foundation in pharmaceutical research and innovation. Her academic journey has been characterized by a strong emphasis on novel drug delivery systems, formulation development, and translational research. She has engaged in continuous professional development, authoring several key texts in Industrial Pharmacy and Modern Dispensing Practices, which are widely used in academic curricula. Her educational background not only reflects depth in pharmaceutical sciences but also showcases her commitment to knowledge dissemination through teaching and publication. Her advanced training and research expertise in nanoformulations, brain-targeted drug delivery, and topical therapeutic systems underscore her position as a subject matter expert. Dr. Mathure’s education has enabled her to bridge theory and practice, equipping her with the skills to lead significant research projects, collaborate with industry partners, and mentor future pharmacists and researchers.

🧪 Experience

With over 15 years of academic and research experience, Dr. Dyandevi Mewalal Mathure has built a distinguished career as an Assistant Professor at Bharati Vidyapeeth, Poona College of Pharmacy, Pune. Her professional journey encompasses extensive teaching, research supervision, and collaborative research projects. She has published 18 papers in esteemed SCI and Scopus-indexed journals, authored three textbooks, and successfully filed five patents. Dr. Mathure has completed one funded research project and is currently engaged in an ongoing industry consultancy project, demonstrating her ability to translate academic research into practical applications. Her collaborations with institutions like the University of Petroleum and Energy Studies highlight her commitment to multidisciplinary research. Additionally, her expertise in nanoformulations for Alzheimer’s disease, wound healing, and skin disorders reflects her diverse research interests. Through her dedicated mentorship and active participation in international conferences, she continues to inspire and guide students, contributing significantly to the advancement of pharmaceutical sciences.

🏅 Awards and Honors

Dr. Dyandevi Mewalal Mathure has been recognized for her outstanding research contributions through multiple awards and honors. Notably, she received the Best Paper Presentation Award at the international e-Conference on “Expanding Frontier of Pharmaceutical Research Towards Global Exigency,” organized by Karpagam College of Pharmacy in association with the Indian Pharmaceutical Association, Coimbatore Branch. Her consistent scholarly excellence is reflected in her extensive publication record and successful patent filings. Dr. Mathure’s innovative work has garnered appreciation from both academia and industry, enhancing her reputation as a leader in pharmaceutical research. In addition to her academic accolades, her active involvement in consultancy projects further validates the real-world impact of her research. Her sustained commitment to innovation, teaching excellence, and translational research has made her a strong contender for the Best Research Award, recognizing her as a role model in the field of pharmaceutical sciences.

🔬 Research Focus

Dr. Dyandevi Mewalal Mathure’s research focuses on developing advanced nanoformulations aimed at treating Alzheimer’s disease, promoting wound healing, and addressing various dermatological conditions through innovative topical formulations. Her work emphasizes the design and optimization of novel drug delivery systems that enhance therapeutic efficacy and patient compliance. Through her publications, patents, and consultancy projects, Dr. Mathure has contributed to the advancement of brain-targeted drug delivery, an area critical for managing neurodegenerative diseases. Her translational research bridges laboratory discoveries with clinical and industrial applications, offering practical solutions to complex medical challenges. Collaborations with reputed institutions like UPES Dehradun further demonstrate her commitment to multidisciplinary and applied pharmaceutical research. With a citation index of 6, she maintains an active presence in scientific discourse, continuously advancing the boundaries of pharmaceutical sciences. Her work exemplifies innovation-driven research with tangible societal impact.

✅ Conclusion

Dr. Dyandevi Mewalal Mathure’s distinguished academic career, marked by impactful research in nanoformulations, drug delivery, numerous publications, patents, and active industry collaborations, demonstrates her unwavering commitment to advancing pharmaceutical sciences and improving patient care through innovation and translational research.

Publications

Konrad Talbot | Alzheimer’s Disease | Best Researcher Award

Published on by Cognitive Scientist Awards

Assos. Prof. Dr. Konrad Talbot | Alzheimer’s Disease | Best Researcher Award

Dr. Konrad Talbot is a distinguished neuroscientist and Associate Professor at Loma Linda University School of Medicine, serving in the Departments of Neurosurgery, Pathology & Human Anatomy, and Basic Sciences since 2018. He specializes in investigating the pathogenesis and treatment of neurodegenerative and psychiatric disorders, particularly focusing on brain insulin resistance in Alzheimer’s and Parkinson’s diseases. With a Ph.D. in Physiological Psychology from UCLA and extensive postdoctoral training at the University of Pennsylvania, Dr. Talbot has held faculty and research positions at leading institutions such as Cedars-Sinai, UCLA, and UPenn. He is a highly cited researcher (H-index: 34, 9341 citations), with significant NIH and international grant support. He also serves as an editorial board member, reviewer, and invited speaker at global conferences. His work has influenced both fundamental neuroscience and the development of therapeutic strategies for brain diseases.

Profile

🎓 Education

Dr. Konrad Talbot completed his undergraduate (B.A.), master’s (M.A.), and doctoral (Ph.D.) degrees in Psychology with a specialization in Physiological Psychology at the University of California, Los Angeles (UCLA). His academic path reflects a deep commitment to understanding the biological underpinnings of behavior and brain function. He also received formal teaching certification from UCLA’s Instructor Development Program in 1992. His postdoctoral training included pivotal roles at the University of Pennsylvania’s Department of Pathology and Laboratory Medicine and the Center for Neurodegenerative Disease Research (1997–2001), where he developed expertise in brain autopsy and pathology. He furthered his technical capabilities through advanced training in quantitative fluorescence microscopy at Mount Desert Island Biological Laboratory in 2007. His broad educational background forms a strong foundation for his interdisciplinary research and teaching roles across psychology, neurobiology, pathology, and medical sciences.

🧪 Experience

Dr. Talbot’s academic journey spans over three decades, beginning as an Assistant Professor at Mount St. Mary’s College and St. Olaf College, where he taught psychology and mentored numerous students. He transitioned into intensive research roles at the University of Pennsylvania (UPenn) from 1997 to 2012, ascending from postdoctoral investigator to senior research investigator and research faculty. He later held associate research professorships at Cedars-Sinai Medical Center and UCLA. Since 2018, he has served as Associate Professor at Loma Linda University. Dr. Talbot has authored influential studies on brain insulin resistance, taught neuroanatomy to medical residents, supervised postdoctoral and undergraduate research projects, and served in various academic leadership and committee roles. In addition to his research and teaching, he has contributed editorial expertise to high-impact journals and consulted on landmark neuroanatomical atlases. His career reflects a blend of teaching excellence, pioneering research, and interdisciplinary leadership.

🏅 Awards and Honors

Dr. Talbot’s contributions have been widely recognized through prestigious awards and honors. In 2003, he received the T.L.L. Temple Foundation Discovery Award from the Alzheimer’s Association for his groundbreaking work on brain insulin resistance. He was honored as a co-dedicatee of the influential neuroscience text The Mouse Brain in Stereotaxic Coordinates (2008 edition), highlighting his impact on anatomical brain mapping. In 2020, he was inducted into the Sigma Chi Scientific Research Honor Society. His professional affiliations include long-standing memberships with the Society for Neuroscience, Alzheimer Research Forum, Schizophrenia Research Forum, and ISTAART (International Society to Advance Alzheimer Research and Treatment). He has played leadership roles in organizing major scientific conferences, chaired institutional committees, and served on advisory panels. His editorial contributions and invited lectures worldwide further underscore the scientific community’s high regard for his research excellence and thought leadership.

🔬 Research Focus

Dr. Talbot’s research centers on identifying and targeting mechanisms underlying neurodegenerative and psychiatric diseases, with a special emphasis on insulin resistance in the brain. He has pioneered investigations showing that brain insulin resistance plays a critical role in Alzheimer’s and Parkinson’s disease pathogenesis. His NIH-funded work explores the therapeutic potential of incretin receptor agonists—an emerging class of antidiabetics—in reducing brain insulin resistance and improving cognitive function. His collaborative projects with institutions like CUNY, UCLA, and the University of Washington focus on both human brain tissue analysis and preclinical models. Past research includes the molecular biology of schizophrenia, especially dysbindin-related pathways. He holds a U.S. patent application on methods for treating brain insulin resistance, signaling the translational potential of his findings. Dr. Talbot’s research integrates neuropharmacology, pathology, neuroanatomy, and clinical neuroscience, aiming to develop disease-modifying treatments that can halt or reverse progression in cognitive and psychiatric disorders.

✅ Conclusion

Dr. Konrad Talbot is an accomplished neuroscientist whose multidisciplinary work in brain insulin resistance has significantly advanced understanding and treatment approaches for Alzheimer’s and Parkinson’s diseases, blending rigorous research, impactful teaching, and translational innovation.

Publications

Forshing Lui | Neurology | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof. Forshing Lui | Neurology | Best Researcher Award

Dr. For-Shing Lui, a U.S. citizen and licensed neurologist in California, the UK, and Hong Kong, is an esteemed academic and clinician with over four decades of international experience in neurology and internal medicine, currently serving as Professor of Neurology at California Northstate University College of Medicine (CNUCOM), where he contributes significantly to medical education, curriculum development, and professional regulatory boards.

Profile

Education 🎓

Dr. Lui completed his M.B.B.S. from the University of Hong Kong in 1978, followed by an internal medicine residency (1978–1982) at the same institution; he then undertook neurology fellowship training at Newcastle General Hospital, UK (1982–1984), and a neurology residency at UC Davis (1995–1999), also serving as Chief Resident; his qualifications include being a Diplomate of the American Board of Psychiatry and Neurology, Fellow of the Royal College of Physicians (Edinburgh), Fellow of the Hong Kong Academy of Medicine, and Fellow of the American Academy of Neurology.

Experience 👨‍🏫

Dr. Lui has served as Expert Consultant and Reviewer for the Medical Board of California, Professor and Course Director at CNUCOM since 2014, Chair of Clinical Sciences, and Vice Chair of Education; formerly, he was Staff Neurologist and Chief of Neurology at Kaiser Permanente, Clinical Professor at UC Davis, and practiced as a neurologist and internist in Hong Kong; his roles spanned clinical practice, academic leadership, curriculum design, quality assurance, and international consultancy.

Awards & Recognitions 🏅

Dr. Lui received the 2022 A.B. Baker Teacher Recognition Award from the American Academy of Neurology, the ITLE University Distinguished Teacher Award in 2021, and multiple CNUCOM Professor of the Year Awards (2019–2023); his national recognitions include listings in America’s Top Physicians and Sacramento Magazine’s Top Doctors; he won the Croucher Fellowship (1982), John Anderson Gold Medal (1978), and several medical school scholarships for academic excellence, including the Li Shu Fan Prize in Pharmacology.

Research Interests 🔬

Dr. Lui’s academic and clinical interests lie in neurology education, vascular neurology, neuroimaging, and multiple sclerosis, with a deep commitment to medical pedagogy and curriculum leadership; his research integrates neurodiagnostic techniques with clinical neurology, particularly in imaging-based teaching, and he has presented regularly at neuroradiology conferences and contributed to educational innovation in neurology training at both Kaiser Permanente and CNUCOM, reflecting a lifelong dedication to mentoring, patient care, and advancing neurologic knowledge.

Publications

Vahid Rashedi | Alzheimer’s disease | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Vahid Rashedi | Alzheimer’s disease | Best Researcher Award

Dr. Vahid Rashedi 👨‍⚕️, an esteemed Assistant Professor of Gerontology at the University of Social Welfare and Rehabilitation Sciences 🇮🇷, has made outstanding global contributions in aging, cognition, and psychogeriatrics 🌍🧠. With a Ph.D. in Gerontology (2017) 🎓 and extensive editorial duties across high-impact journals 📚, he’s actively involved as a Senior Collaborator with the Global Burden of Disease Project at IHME, University of Washington 🇺🇸. Recognized as a Top 1% scientist by Stanford University in 2024 🏅, he combines academic excellence, innovation, and impactful research. His interdisciplinary work spans gerontology, rehabilitation, mental health, and cognitive science, cementing his status as a global leader in aging research 🌐💡.

Profile

Education 🎓

Dr. Rashedi began his academic path with a Bachelor’s and Master’s degree in Rehabilitation Sciences 🎓🦾, focusing on geriatric care and assistive technology. He earned his Ph.D. in Gerontology with distinction in 2017 🥇, building expertise in psychogeriatrics, mental health, and cognitive decline. His academic training was rooted in interdisciplinary frameworks linking medicine, psychology, and social work 🔬💬. This diverse education empowered him to bridge clinical insights with research, enabling innovative health solutions for elderly populations 👵👴. He complements formal education with global scientific memberships and ongoing collaborations with prestigious institutes, such as IHME 🌎, emphasizing lifelong learning and cutting-edge research.

Experience 👨‍🏫

Dr. Rashedi has over a decade of rich academic and research experience, currently serving as Assistant Professor at the University of Social Welfare and Rehabilitation Sciences 🏫. Since 2019, he has been a Senior Collaborator at IHME, University of Washington, contributing to the Global Burden of Disease project 📊🌐. He has authored 126 indexed journal articles 📑, published a book 📖, and holds four patents, including rehabilitation innovations like the vibrating ankle-foot orthosis 🦿. He is a prolific editorial board member and associate editor for over 10 international journals 📘🖋️. His work in psychogeriatrics and cognition has garnered global recognition, highlighting his leadership and mentoring roles 👨‍🏫🏅.

Awards & Recognitions 🏅

Dr. Rashedi is recognized globally for his scientific excellence, notably ranked in the Top 1% of scientists worldwide by Stanford University in 2024 🌟📈. He holds editorial roles in Frontiers, CGJ, and the Journal of Gerontology, reflecting scholarly esteem 📚. He is a trusted reviewer for numerous high-impact journals and was honored with national and international awards 🥇. His patented inventions in geriatric rehabilitation demonstrate a blend of innovation and clinical value 💡🏥. His GSA, APA, and ISTAART memberships validate his international standing 👏🌐. These honors underscore his unwavering dedication to improving elderly lives through evidence-based science and collaboration 🤝

Research Interests 🔬

Dr. Rashedi’s research delves into psychogeriatrics, mental health, and cognitive disorders in aging populations 🧠👴. As part of the Global Burden of Disease team at IHME 🌍, he contributes to global health analytics, shaping international aging policies 📊. His innovations include assistive devices with therapeutic functions, bridging technology and clinical rehabilitation 🛠️⚙️. With 63 research projects and over 26,000 citations 🔍📈, his scholarly output is extensive and impactful. He leads investigations on dementia, geriatric depression, and cognitive resilience, supported by his roles in editorial boards and scientific societies 🧬📘. His mission is to translate research into real-world health solutions for aging communities 🌟🩺.

Publications 

LUCIANO VITORINO | Cognitive Aging | Cognitive Aging Excellence

Published on by Cognitive Scientist Awards

Dr. LUCIANO VITORINO | Cognitive Aging | Cognitive Aging Excellence

Dr. Luciano Magalhães Vitorino, Ph.D., RN 🇧🇷 is a dedicated professor at the Faculty of Medicine of Itajubá, Brazil 🏥, with expertise in nursing, gerontology, spirituality, and health 🌱. He has built a multidisciplinary academic and research career blending healthcare, cognition, and spirituality 🧠🙏. With over 1,500 citations 📚 and extensive teaching roles in medicine and nursing 🩺, he leads the Research Center and the Assessment Center at FMIT, actively contributing to the Research Ethics Committee 👨‍🔬. His international academic collaborations, including the University of Alberta 🇨🇦, reflect his global engagement 🌍. A recognized academic voice, he served as Guest Editor for Frontiers in Psychiatry 📰 and holds memberships across academic platforms 📊. Through education, mentorship, and pioneering research, Dr. Luciano is influencing healthcare for the aging population 💡👴👵.

Profile

Education 🎓

Dr. Luciano holds a Postdoctoral Fellowship in Cognition, Spirituality, and Aging from UFJF (2017–2019) 🧘‍♂️🧠, a Ph.D. and M.Sc. in Quality of Life & Spiritual Health from UNIFESP (2012–2016) 📖, and a B.Sc. in Nursing from Faculty of Nursing Wenceslau Braz (2006) 🩺. He specialized in Urgency and Emergency Care (2008–2010) ⛑️. His Ph.D. work was guided by experts from UNIFESP and the University of Alberta 🇨🇦, exploring spiritual/religious coping among older adults. His dissertation and thesis focused on quality of life and religious coping in nursing homes and community settings 🙏🏘️. His postdoctoral project assessed spirituality’s influence on cognitive decline in aging populations 🧓. This unique education, combining nursing, public health, and spirituality, positions him as a thought leader in holistic geriatric care

Experience 👨‍🏫

Dr. Luciano is a full-time assistant professor at FMIT since 2018 👨‍🏫. He coordinates both the Research Center (since 2022) and Assessment Center (since 2022), and is a long-standing member of the Research Ethics Committee (since 2019) 🧪📋. He previously taught at Faculty of Nursing Wenceslau Braz (2007–2012), Medical School of Itajubá (2013–2014), and Federal University of São Paulo (2013) 👨‍⚕️📘. He’s also guided health residency programs and coordinated caregiver training for elderly individuals 👵👨‍⚕️. As Guest Editor of Frontiers in Psychiatry (2022–2023), he shaped international discussions on spirituality and health 🗞️🕊️. His teaching subjects include Epidemiology, Geriatrics, Medical Semiology, and Spirituality & Health 🧬🩻. His roles reflect a passion for interdisciplinary health sciences and dedication to ethical, evidence-based care 🌟.

Awards & Recognitions 🏅

Dr. Luciano’s impactful research and teaching have earned him numerous citations across Scopus (h-index 13, 525 citations), Web of Science (h-index 11, 454 citations), Google Scholar (h-index 20, 1,506 citations) 📈, and ResearchGate (h-index 16, 864 citations) 🧑‍🔬. His inclusion as Guest Editor for Frontiers in Psychiatry (2022–2023) showcases recognition in global academic communities 🌍. He’s contributed to leading Brazilian and international institutions like UNIFESP, UFJF, and the University of Alberta 🇧🇷🇨🇦. Through strong publication records and global collaborations, he’s established himself as an authority on spiritual health in aging 🚀📚. His profile on Google Scholar, ORCID, and LinkedIn reflects international engagement and scholarly distinction 🌐🎖️.

Research Interests 🔬

Dr. Luciano’s research bridges Geriatrics, Gerontology, Spirituality and Mental Health, and AI in Healthcare 🧓🧠💻. His central interest lies in understanding how spirituality and religiosity affect cognitive aging and quality of life 🌿🧘‍♂️. His postdoctoral research—a 4-year longitudinal study—explored how spiritual coping impacts cognitive decline in community-dwelling elders 🧪🕯️. He also investigates medical education, primary healthcare, and interdisciplinary training 🩺📘. As AI transforms healthcare, he examines its integration with geriatric care and spiritual health frameworks 🤖❤️. Through mixed-methods research and international collaboration, he aims to personalize elderly care and mental wellness using both humanistic and data-driven approaches 📊✨.

Publications 

Jeevitha Gowda R | Cognitive impairment | Best Researcher Award

Published on by Cognitive Scientist Awards

Ms. Jeevitha Gowda R | Cognitive impairment | Best Researcher Award

Assistant Professor, Alliance University, United Kingdom

🧠 Dr. Jeevitha Gowda R is a dedicated research scholar specializing in cognitive neuroscience and public health, with a strong focus on dementia prevention. She has expertise in developing cognitive screening tools, conducting neuropsychological assessments, and designing neuroscience-based interventions to enhance brain health. Currently serving as a Guest Faculty and Research Associate, she is passionate about bridging research with real-world applications. With proficiency in EEG, ERP, and data analysis, her work emphasizes cognitive aging, behavioral psychology, and mental well-being. Her research contributions include multiple conference presentations, publications, and cognitive training programs. She has received prestigious recognitions, including Best Paper Awards and research fellowships. Her commitment extends to community mental health programs, where she collaborates with NGOs and research institutions. Through her work, she aims to advance cognitive neuroscience and improve public health outcomes. 📚🔬

Profile

Education 🎓

🎓 Dr. Jeevitha Gowda R holds a Ph.D. in Cognitive Neuroscience and Public Health from Ramaiah University of Applied Sciences, Bengaluru (Thesis Submitted), focusing on developing cognitive tools for early dementia detection in primary healthcare settings. She earned a Master’s in Cognitive Neuroscience from JSS Academy of Higher Education, Mysuru (2018), ranking among the top 3 students, with coursework in neural cognition, psychological assessment, and clinical interventions. Her dissertation explored mental fatigue due to sleep deprivation using EEG and ERP. She completed her Bachelor’s in Life Sciences from JSS College for Women, Mysuru (2016), excelling in biochemistry, microbiology, and environmental psychology. Additionally, she trained at the Defence Institute of Psychological Studies (DRDO) and Narayana Health, Bengaluru, gaining hands-on experience in EEG, neuropsychological assessments, and cognitive therapy. Her interdisciplinary education combines neuroscience, psychology, and public health, preparing her for impactful research and innovation in brain health. 🧠📖

Experience 👨‍🏫

💼 Dr. Jeevitha Gowda R has extensive experience as a Research Associate at the Centre for Integrative Health and Well-Being (2020–Present), where she develops neuropsychological intervention tools and conducts cognitive behavioral therapy (CBT) programs. She also serves as a Senior Research Associate at Brighter Minds, focusing on cognitive enhancement and neuroscience-based training programs. As a Guest Lecturer at Ramaiah University of Applied Sciences (2021–Present), she teaches biostatistics, neurophysiology, and psychology. Her past clinical internships at DRDO and Narayana Health provided her with hands-on expertise in EEG, ERP, and neuropsychological assessments. She has conducted research on cognitive impairment, dementia screening, and sleep deprivation’s effects on cognition. Additionally, she has authored 50+ neuroscience articles, presented at international conferences, and collaborated with NGOs for mental health awareness. Her diverse experience integrates academic, clinical, and research-based expertise to advance cognitive neuroscience and public health. 🏥📊

Research Interests 🔬

🔬 Dr. Jeevitha Gowda R’s research bridges cognitive neuroscience, psychology, and public health, focusing on early dementia detection, cognitive aging, and neuropsychological interventions. She specializes in developing culturally relevant cognitive screening tools for primary healthcare, improving accessibility to dementia diagnostics. Her work explores neuropsychological assessments, EEG-based cognitive analysis, and behavioral interventions for enhancing mental well-being. She has conducted studies on sleep deprivation, cognitive impairment, and neurofeedback therapy. She collaborates with institutions like DRDO, Narayana Health, and Brighter Minds to implement neuroscience-driven programs. Her research extends to the psychological well-being of dementia caregivers, neurocognitive training for brain health, and integrating technology into mental health solutions. Through interdisciplinary studies and global research collaborations, she aims to advance early dementia detection methods and improve cognitive health strategies. Her work contributes to policy-making, clinical psychology, and public health initiatives. 🏥📊

Awards & Recognitions 🏅

🏆 Dr. Jeevitha Gowda R has received multiple accolades for her contributions to cognitive neuroscience and public health research. She won the Best Paper Award at the Epidemiology Foundation of India Conference (2023, Goa) for her groundbreaking work on dementia screening. Her research paper on cognitive tool validation earned a Special Mention at the International Dementia Conference (DEMCON-2024, IISC Bangalore). During her master’s, she ranked among the top 3 dissertations at JSS Academy of Higher Education. She was awarded the Senior Research Fellowship (SRF) by Ramaiah University of Applied Sciences (2022–2024) for her Ph.D. research. She has also secured research grants for projects on dementia detection and cognitive enhancement. Recognized for her impactful contributions, she collaborates with prestigious institutions, including DRDO and Narayana Health, to advance neuropsychological research. Her work continues to shape innovations in mental health and aging. 🎖️🧠

Publications 📚

  • Jeevitha Gowda R, Anish Mehta, Krishnamurthy Jayanna. (2025).
    Dementia: A Public Health Challenge in India. South Eastern European
    Journal of Public Health, 29–43. Retrieved from
    hps://www.seejph.com/index.php/seejph/article/view/3295 (Scopus)

  • Jeevitha Gowda R. The Impact of Cultural Beliefs and Stigma on
    Dementia Care and Diagnosis: A Scoping Review, 25 November 2024,
    PREPRINT (Version 1) available at Research Square
    hps://doi.org/10.21203/rs.3.rs-5519592/v1
  • Jeevitha Ramesh, Parimala Guruprasad (2024) Factors Affecting the
    Psychological Well-Being of Caregivers of Dementia Patients: A
    Thematic Review. Journal of Neurology Research Reviews & Reports.
    SRC/JNRRR-260
  • Development and Validation of Cognitive Screening Tools for
    Dementia Detection in Primary Care Seings: An Exploratory Pilot
    Study – Under review at International Journal of Geriatric Psychiatry.
    (Corresponding Author)
  • Burden of Cognitive Impairment Including Dementia, and Associated
    Risk Factors Among the Rural Population of South Karnataka, India –
    Under review at Journal of Public Health Research. (Corresponding
    Author)
  • Impact of Training Module on Lifestyle and Healthy Behaviours: An
    Exploratory Pilot in India – Under review at Journal Explore.
    (Co-Author)

Carmela Conte | Neurodegenerative diseases | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof Dr. Carmela Conte | Neurodegenerative diseases | Best Researcher Award

 

Profile

Education

Carmela Conte obtained her Master’s degree in Biological Sciences from the University of Perugia on November 3, 1994. She then pursued a Ph.D. in Medical Embryology through a joint program between the Universities of Perugia and Ferrara, completing it between December 30, 1996, and January 19, 2000. Following this, she specialized in Chemistry and Food Technology at the University of Perugia, earning her specialization between November 1, 2000, and November 1, 2002. Most recently, on September 29, 2023, she received National Habilitation as an Associate Professor in Biochemistry. She currently serves as an Aggregate Professor in her field.

Work experience

Since September 7, 2007, Carmela Conte has been serving as an Aggregate Professor in Biochemistry at the University of Perugia, where she teaches courses in General and Systematic Biochemistry, Medical Applied Biochemistry, and Molecular Biology. In addition to her teaching responsibilities, she participated in a Teaching and Training Mobility Program at VUMC Medical University of Amsterdam from June 24 to July 5, 2019, where she worked on a research project investigating the role of Toll-like receptors in Parkinson’s disease. She has been a member of the European Society for Neurochemistry since 2007 and, since March 17, 2022, has also been affiliated with the International Parkinson and Movement Disorder Society.

Research Activity

Carmela Conte’s research focuses on neurodegenerative diseases, with particular emphasis on animal models, signal transduction, molecular biology, and cell biology. Her specific research topics include the role of Toll-like receptors in Parkinson’s disease, neuroinflammation, synucleinopathies, oxidative stress, and Parkinson’s disease. Since September 7, 2007, she has been actively involved in editorial work, serving as a Reviewer Editor for Frontiers in Neuroscience (Neurodegeneration section) and as an ad hoc reviewer for several journals, including Amino Acids, The Cerebellum, Free Radical Research, Biomolecules, PLOS One, Experimental Gerontology, Molecules, Cells, Neurochemical Research, Neuroscience, Pharmacological Reports, International Journal of Molecular Sciences, Viruses, and the Journal of Biotechnology. Additionally, she has been a Guest Editor for Molecules and Cells, overseeing special issues and topic collections on neurodegenerative diseases. She has presented her research at numerous scientific meetings and conferences, including the 2009 Meeting of the European Society for Neurochemistry in Leipzig, the 2019 European Biotechnology Congress in Valencia, the 2021 European Biotechnology Congress in Sofia, the 2022 National Meeting of the Sphingolipid Club, and the 2023 Meeting of Parkinson’s Disease and Movement Disorders, where she discussed findings related to Toll-like receptor 4, alpha-synuclein accumulation, and sphingomyelinase activity in Parkinson’s disease models.

Publication